Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Comment by skiptoggleon Dec 09, 2019 2:43pm
100 Views
Post# 30436796

RE:RE:RE:Condensate was $82.28 today

RE:RE:RE:Condensate was $82.28 todayTuco, would you say that you'd love to see impairment charges resulting form $120 condensate if PIPE hedged 90% of production in 2020?  I don' think so.  Also I don't think that impairment charges in general are a good thing.  Can you explain why this would be good for shareholders and to the valuation of the company?

I support the hedging program because it provides stability and that is what PIPE needs in 2020.  The 46% of 2020 is a fair balance between stability and seeing the benefit of an upside.  In terms of revenue lets not forget that ~50% of production is NGL.  So we are looking at an earnings boost on 1/2 of 54% of production based on condensate price.  Also base model prices are for $55 US WTI which is closer to $73 CDN. So yes, we are going to see a benefit from rising condensate, just temper our expectations with the fact that not all production will benefit from the increase.  Conversely we are somewhat sheltered from any downturns.


Tuco110 wrote: Ruud, you keep refering back to the hedging program as a drag on revenue growth. Remember that the hedging is not at base model prices of $70 but closer to $78. You seem to be forgeting that even at hedged prices the company is making more than forecast in their production models. I agree that if condensate prices continue to raise it will result in commodity impairment charges on the financials but those are non cash accounting adjustments that don't affect cashflow. I personally would love to see impaiment charges that account for $120 condensate.


<< Previous
Bullboard Posts
Next >>